Biotech RadarJobs updated

COMPANY

Dogwood Therapeutics

HQ: Alpharetta, GA source · dwtx.com ↗ · Southeast

Dogwood Therapeutics is listed on ClinicalTrials.gov as the lead sponsor of 1 study; the most recently updated is “Efficacy and Safety Study of Halneuron in the Treatment of Chemotherapy-Induced Neuropathic Pain” (Phase 2, active not recruiting), in Chemotherapy Induced Neuropathic Pain, Chemotherapy Induced Pain Neuropathy, Chemotherapy Induced Pain. From public records Source · Oct 12, 2026

Keywords: neuropathy

Location: Alpharetta, GA · source · Oct 14, 2026

Profile checked Oct 10, 2026

$53.6MRaised (2 yrs)

Raises and deals from press releases

Raises announced in these releases: $5M disclosed.

From the company’s own releases; this list is partial. All raises and deals

Timeline

  1. Raise Private placement · $5M source ↗
  2. Raise Private placement: $26.8M (up to, as announced), announced Jan 12, 2026. Source: company release on GlobeNewswire. source ↗
  3. Partnership Partnership / licensing announced Sep 29, 2025. Source: SEC filing. source ↗
  4. Raise Private placement: $26.8M (up to, as announced), announced Jan 12, 2025. Source: SEC filing. source ↗

Funding

Raised: $53.6M. Last 2 years.

Feedback